US Stock MarketDetailed Quotes
NVRO Nevro
- 4.440
- +0.210+4.96%
Trading Nov 21 15:45 ET
166.37MMarket Cap-2374P/E (TTM)
4.470High4.205Low307.16KVolume4.250Open4.230Pre Close1.35MTurnover0.84%Turnover RatioLossP/E (Static)37.47MShares22.64052wk High0.61P/B161.63MFloat Cap3.95052wk Low--Dividend TTM36.40MShs Float188.140Historical High--Div YieldTTM6.27%Amplitude3.950Historical Low4.382Avg Price1Lot Size
About Nevro Company
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Company Profile
SymbolNVRO
Company NameNevro
Listing DateNov 6, 2014
Issue Price18.00
Founded2006
CEOMr. Kevin R. Thornal
MarketNYSE
Employees1215
Fiscal Year Ends12-31
Address1800 Bridge Parkway
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-251-0005
Websitehttp://www.nevro.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Thornal
- Director, Chief Executive Officer and President
- 11.45M
- Greg Siller
- Senior Vice President and Chief Commercial Officer
- 3.56M
- Kashif Rashid
- Senior Vice President, Corporate Development and Chief Legal Officer
- 2.55M
- Shana Ross
- Senior Vice President and Chief Human Resources Officer
- --
- Dr. David Caraway, PhD
- Senior Vice President and Chief Medical Officer
- --
- Christopher Christoforou
- Chief Operating Officer
- --
- Roderick H. MacLeod
- Senior Vice President and Chief Financial Officer
- 2.58M
- Peter A. Socarras
- Vice President, General Counsel and Corporate Secretary
- --
- Donald A. Middlebrook
- Senior Vice President, Clinical, Regulatory and Quality
- --
- D. Keith Grossman
- Non-Executive Chairman of the Board
- 1.36M
- Kirt P. Karros
- Independent Director
- --
- Susan E. Siegel
- Independent Director
- 242.99K
- Sri Kosaraju
- Independent Director
- 242.99K
- Kevin O’Boyle
- Independent Director
- 259.99K
- Michael F. DeMane
- Lead Independent Director
- 284.99K
- Karen N. Prange
- Independent Director
- 252.99K
- Shawn T. McCormick
- Independent Director
- 246.99K
- Elizabeth H. Weatherman
- Independent Director
- 259.24K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data